Skip to main content

Table 4 Characteristics of each cost-effectiveness analysis (CEA) for diabetic ulcers (n = 16)

From: A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

CEA (Original year of values) Country (Original currency) Perspective Efficacy study design Sample size Population Timeframe Funding source a
Abidia 2003 (2000) [48] UK (£) Not reported RCT 18 Mean 71 yrs; diabetes 52 wks Not reported
Apelqvist 1996 (1993) [49] Sweden (SEK) Society RCT 41 Included >40 yrs; diabetes 12 wks Mixed
Edmonds 1999 (1996) [50] UK (£) Provider RCT 40 Mean 66 yrs; diabetes; foot infections 2 wks Private
Guo 2003 (2001) [51] USA (US$) Society SRb 126 60 yrs; diabetes 12 yrs Not reported
Habacher 2007 (2001) [52] Austria (€) Society Observational 119 Mean 65 yrs; diabetes 15 yrs Not reported
Horswell 2003 (1999) [53] USA (US$) Not reported Observational 214 Mean 54 yrs; diabetes; mostly African-Americans 52 wks Not reported
Jansen 2009 (2006) [54] UK (£) Public payer RCT 402 Mean 58 yrs; diabetes approx. 4 wks Private
Jeffcoate 2009 (2007) [55] UK (£) Public payer RCT 317 Mean 60 yrs; diabetes 24 wks Public
McKinnon 1997 (1994) [56] USA (US$) Provider RCT 90 Mean 60 yrs; diabetes; limb-threatening foot infections 3 wks Private
Persson 2000 (1999) [57] Sweden (US$) Not reported SR of RCTs 500 Median 60 yrs; diabetes 52 wks Private
Piaggesi 2007 (2006) [58] Italy (€) Not reported RCT 40 Mean 60 yrs; diabetes 12 wks Private
Redekop 2003 (1999) [59] The Nether-lands (€) Society RCT 208 Elderly; diabetes 52 wks Private
Allenet 2000 (1998) [60] France (FF) Society RCT 235 Diabetes; (ages not reported) 52 wks Not reported
Ghatnekar 2002 (2000) [61] France (€) Not reported RCT 157 Diabetes; (ages not reported) 52 wks Private
Ghatnekar 2001 (1999) [62] UK(US$) Public payer SR of RCTs 449 Diabetes; (ages not reported) 52 wks Private
Hailey 2007 (2004) [63] Canada (CAN$) Public payer SR of RCTs 305 65 yrs; diabetes 12 yrs Public
  1. RCT, Randomized clinical trial; SR, Systematic review; wks, Weeks; yrs, Years.
  2. aMixed here indicates both private and public funding.
  3. bNot specified if the included studies were RCTs or not (but states they were prospective controlled clinical studies).